Cargando…
Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives
Type 1 diabetes (T1D) is caused by autoimmune destruction of insulin-producing β cells located in the endocrine pancreas in areas known as islets of Langerhans. The current standard-of-care for T1D is exogenous insulin replacement therapy. Recent developments in this field include the hybrid closed-...
Autores principales: | Pathak, Varun, Pathak, Nupur Madhur, O’Neill, Christina L, Guduric-Fuchs, Jasenka, Medina, Reinhold J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501476/ https://www.ncbi.nlm.nih.gov/pubmed/31105434 http://dx.doi.org/10.1177/1179551419844521 |
Ejemplares similares
-
Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types
por: Guduric-Fuchs, Jasenka, et al.
Publicado: (2012) -
Long term high glucose exposure induces premature senescence in retinal endothelial cells
por: Bertelli, Pietro Maria, et al.
Publicado: (2022) -
Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood‐Derived Endothelial Colony‐Forming Cells for Ischemic Retinopathies
por: Reid, Emma, et al.
Publicado: (2017) -
Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities
por: Medina, Reinhold J, et al.
Publicado: (2010) -
The Vasoreparative Potential of Endothelial Colony Forming Cells: A Journey Through Pre-clinical Studies
por: O'Neill, Christina L., et al.
Publicado: (2018)